CRS-35 Packs Brain Models and Superbugs for the ISS

NASA’s October 12 research briefing assigned four biological investigations to SpaceX’s CRS-35 cargo flight to the International Space Station. The payload includes lab-grown human brain models, fungus-infected plants, materials for an onboard health assay and an investigation of antibiotic-resistant bacteria on station surfaces. Each asks a different question about living systems or health monitoring in orbit.

As of 11:58 UTC on October 13, the SpaceX CRS-35 mission page still described a 10:33 UTC launch from Cape Canaveral, Florida, as a target and an October 15 docking as planned; it carried no completed-flight update. The published launch time has passed, but that page does not establish whether Dragon has lifted off. The research assignments are confirmed; the flight status needs a post-launch mission update.

Four payloads, four biological questions

The brain and crop investigations compare material exposed to spaceflight with material kept on Earth. The health-assessment test asks whether an instrument already aboard the station can deliver useful measurements there. The bacteria investigation follows organisms in the station environment over repeated sampling. Those different designs also set limits on what each result can establish.

• Brain models: what changes in human brain cells during spaceflight? The AVATAR-Org1 investigation sends small, lab-grown tissue models called miBrains to the ISS for five weeks and compares them with models kept on Earth. NASA’s AVATAR-Org1 outline describes the models as containing the primary cell types of human brain tissue. Differences between the flight and Earth samples could identify cellular responses for further study. The work also tests whether researchers can reliably grow and monitor this tissue in space. A tissue model cannot establish how an astronaut’s whole brain functions or diagnose a neurological condition.
• Crop disease: does infection develop differently in microgravity? MVP-Plant-02 compares molecular and structural changes in fungus-infected plants grown on the station and on Earth. The plant investigation outline identifies faster or more severe disease in microgravity as the hypothesis under test, rather than a result already observed. A difference could guide later work on disease-resistant crops and ways to protect food production during space missions. This comparison alone cannot show that every crop or fungus responds in the same way, or separate gravity from every other condition of a spaceflight.
• Rapid health assessment: can samples be analyzed aboard the station? Cargo on this flight supports the first test of a compact microplate reader that arrived at the ISS earlier this year. The planned assay measures biomarkers such as antibodies, antigens and proteins. If the reader yields useful measurements in orbit, researchers could obtain some data without waiting for samples to return to Earth. The test concerns the instrument’s ability to perform an onboard analysis; it does not by itself validate a clinical diagnosis or establish that a crew member has an infection.
• Antibiotic resistance: which organisms persist on station surfaces? Astronauts will repeatedly sample surfaces for the continuing GEARS investigation, which is returning for its final planned stay. NASA’s GEARS outline identifies resistant Enterococcus faecalis and Enterococcus faecium among its organisms of interest. Repeated collections can help show where resistant bacteria are found and how they change in an enclosed orbital environment. Detecting bacteria on a surface does not establish that they infected an astronaut or that microgravity alone caused their resistance.

Why these tests belong on the station

The flight-versus-Earth comparisons give the brain and plant teams observations they cannot obtain from Earth samples alone. For miBrains, the useful signal would be a measurable cellular difference between matched tissues after the flight interval. For infected plants, it would be a difference in disease development or in the plant’s molecular and structural response. Either finding would provide a question for follow-up experiments, rather than an immediate treatment or a ready-to-grow crop.

The microplate reader and GEARS address the time and distance involved in protecting a crew. An assay performed aboard the ISS could provide information sooner than one dependent on a returned sample. Surface sampling, meanwhile, records what is present in the shared habitat across repeated collections. Those measurements serve different purposes: one evaluates an analysis tool, while the other surveys organisms that may pose a health risk.

Potential benefits on Earth are similarly specific. The crop comparison may help researchers investigate traits associated with disease resistance. Findings from GEARS may add to understanding of how resistant bacteria persist in enclosed environments. Neither application follows automatically from sending a sample into orbit; researchers first need the measured differences and, where relevant, further tests of their causes.

The next observations

After a confirmed flight update, Dragon’s planned docking would make the research cargo available to the station crew. The investigations then move on different clocks: the brain models require their planned stay in orbit, the infected plants must be grown and examined, the reader must produce assay data, and GEARS depends on repeated surface collections.

The first meaningful results will be the comparisons and measurements from those operations. They will show whether the brain tissue and infected plants changed under the study conditions, whether the reader can return useful onboard data, and what the bacteria survey finds over time.

Also read:

• NASA Astronaut Chris Williams Returns After 241 Days on the ISS
• LLMs Explained: How Large Language Models Work (and Where They Commonly Fail)
• Ask Your Question to Ten AI Models Simultaneously with This Game-Changing Tool